Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

38.18
Delayed Data
As of Aug 07
 -1.57 / -3.95%
Today’s Change
14.16
Today|||52-Week Range
50.49
+22.18%
Year-to-Date
No recent news for Y-mAbs Therapeutics, Inc.

Today’s Trading

Previous close39.75
Today’s open39.09
Day’s range37.72 - 40.50
Volume9,062
Average volume (3 months)235,273
Market cap$1.5B
Data as of 3:59pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)-53.12%
Earnings growth (this year)-23.72%
Earnings growth (next 5 years)-47.40%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.60

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.12-1.08%
MGNXMacroGenics Inc-0.03-0.11%
----
CYTKCytokinetics Inc-0.15-0.69%
Data as of 4:33pm ET, 08/07/2020

Financials

Next reporting dateNovember 11, 2020
EPS forecast (this quarter)-$0.76
Annual revenue (last year)$0.00
Annual profit (last year)-$81.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts